What Bundibugyo Ebola vaccines and treatments are under development
Global health authorities are working to develop vaccines and treatments for the Bundibugyo strain of Ebola amid an outbreak in the Democratic Republic of Congo. The World Health Organization has identified several experimental candidates, including a promising single-dose vaccine and antibody therapies. The situation remains critical, with the number of cases and deaths expected to rise as efforts to contain the outbreak continue.
- ▪The Bundibugyo strain of Ebola currently has no approved vaccines or treatments.
- ▪The WHO has recommended prioritizing several experimental drugs and vaccines for BDBV.
- ▪A single-dose vaccine candidate, rVSV Bundibugyo, shows promise and is advancing towards clinical trials.
Opening excerpt (first ~120 words) tap to expand
What Bundibugyo Ebola vaccines and treatments are under developmentSign up now: Get ST's newsletters delivered to your inboxA Uganda Red Cross Society worker in protective gear disinfecting the home of a suspected Ebola victim in Kampala on May 26.PHOTO: AFPPublished May 30, 2026, 10:30 AMUpdated May 30, 2026, 10:30 AMGlobal health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo (DRC), linked to the Bundibugyo strain of the virus.Unlike for the more common Zaire strain, there are no approved vaccines or treatments for Bundibugyo.The latest outbreak is suspected to have led to about 906 cases in the DRC, including 223 suspected deaths, with the World Health Organization (WHO) warning that the toll is likely to…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Straits Times — World.